Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mechanism of resistance to ABL tyrosine kinase inhibitor STI-571 explored

Aug. 22, 2000

Dendreon describes therapeutic cancer vaccine technology

Aug. 22, 2000

Antineoplastic agents under development at Merck & Co.

Aug. 21, 2000

Copernicus Therapeutics awarded SBIR grant to develop episomal vectors for breast cancer therapy

Aug. 21, 2000

New series under development at Pharmacia for treatment of cancer

Aug. 18, 2000

Teverelix shows promise in first-dose-in-humans study

Aug. 18, 2000

NIH licensing opportunity: system for functional identification of p53 mutations

Aug. 17, 2000

Licensing opportunity from NIH: gene amplification in cancer

Aug. 17, 2000

NIH licensing opportunity: methods to inhibit cell motility

Aug. 17, 2000

Zarix updates progress on Thymitaq

Aug. 16, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...